Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandra Santoro

Showing results (41-50 of 49) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 49 results.
Pathologica|December 27, 2025
Harmonization trial of <i>FGFR1-3</i> testing strategies in cholangiocarcinoma patients: an Italian multicenter experienceFrancesco Pepe, Gianluca Russo, Claudia Scimone, et al.
Cancer Genetics and Cytogenetics|May 18, 2010
Chromosome abnormalities additional to the Philadelphia chromosome at the diagnosis of chronic myelogenous leukemia: pathogenetic and prognostic implicationsAlfonso Zaccaria, Nicoletta Testoni, Anna Maria Valenti, et al.
Hematological Oncology|October 17, 2022
Circulating cell-free DNA for target quantification in hematologic malignancies: Validation of a protocol to overcome pre-analytical biasesRoberta Soscia, Irene Della Starza, Lucia Anna De Novi, et al.
International Journal of Molecular Sciences|June 12, 2026
Comparative Analysis Between the EuroClonality-NGS Approach and the LymphoTrack<sup>®</sup> Dx Assay for IG/TR Marker Screening in Lymphoid Leukemias: A Campus ALL StudyIrene Della Starza, Vittorio Bellomarino, Mariangela Di Trani, et al.
Diagnostics (Basel, Switzerland)|February 25, 2023
An Italian Multicenter Perspective Harmonization Trial for the Assessment of MET Exon 14 Skipping Mutations in Standard Reference SamplesPaolo Bironzo, Francesco Pepe, Gianluca Russo, et al.
Blood Advances|June 5, 2023
Pegaspargase-modified risk-oriented program for adult acute lymphoblastic leukemia: results of the GIMEMA LAL1913 trialRenato Bassan, Sabina Chiaretti, Irene Della Starza, et al.
Blood|February 26, 2025
Up-front blinatumomab improves MRD clearance and outcome in adult Ph- B-lineage ALL: the GIMEMA LAL2317 phase 2 studyRenato Bassan, Sabina Chiaretti, Irene Della Starza, et al.
Haematologica|May 30, 2020
Philadelphia-like acute lymphoblastic leukemia is associated with minimal residual disease persistence and poor outcome. First report of the minimal residual disease-oriented GIMEMA LAL1913Sabina Chiaretti, Monica Messina, Irene Della Starza, et al.
Human Molecular Genetics|June 19, 2015
AluY-mediated germline deletion, duplication and somatic stem cell reversion in UBE2T defines a new subtype of Fanconi anemiaElizabeth L Virts, Anna Jankowska, Craig Mackay, et al.
Pageof 5

Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Pathologica|December 27, 2025
Harmonization trial of <i>FGFR1-3</i> testing strategies in cholangiocarcinoma patients: an Italian multicenter experienceFrancesco Pepe, Gianluca Russo, Claudia Scimone, et al.
Cancer Genetics and Cytogenetics|May 18, 2010
Chromosome abnormalities additional to the Philadelphia chromosome at the diagnosis of chronic myelogenous leukemia: pathogenetic and prognostic implicationsAlfonso Zaccaria, Nicoletta Testoni, Anna Maria Valenti, et al.
Hematological Oncology|October 17, 2022
Circulating cell-free DNA for target quantification in hematologic malignancies: Validation of a protocol to overcome pre-analytical biasesRoberta Soscia, Irene Della Starza, Lucia Anna De Novi, et al.
International Journal of Molecular Sciences|June 12, 2026
Comparative Analysis Between the EuroClonality-NGS Approach and the LymphoTrack<sup>®</sup> Dx Assay for IG/TR Marker Screening in Lymphoid Leukemias: A Campus ALL StudyIrene Della Starza, Vittorio Bellomarino, Mariangela Di Trani, et al.
Diagnostics (Basel, Switzerland)|February 25, 2023
An Italian Multicenter Perspective Harmonization Trial for the Assessment of MET Exon 14 Skipping Mutations in Standard Reference SamplesPaolo Bironzo, Francesco Pepe, Gianluca Russo, et al.
Blood Advances|June 5, 2023
Pegaspargase-modified risk-oriented program for adult acute lymphoblastic leukemia: results of the GIMEMA LAL1913 trialRenato Bassan, Sabina Chiaretti, Irene Della Starza, et al.
Blood|February 26, 2025
Up-front blinatumomab improves MRD clearance and outcome in adult Ph- B-lineage ALL: the GIMEMA LAL2317 phase 2 studyRenato Bassan, Sabina Chiaretti, Irene Della Starza, et al.
Haematologica|May 30, 2020
Philadelphia-like acute lymphoblastic leukemia is associated with minimal residual disease persistence and poor outcome. First report of the minimal residual disease-oriented GIMEMA LAL1913Sabina Chiaretti, Monica Messina, Irene Della Starza, et al.
Human Molecular Genetics|June 19, 2015
AluY-mediated germline deletion, duplication and somatic stem cell reversion in UBE2T defines a new subtype of Fanconi anemiaElizabeth L Virts, Anna Jankowska, Craig Mackay, et al.
Pageof 5